Literature DB >> 27042839

Hematopoietic cell transplantation in older adults: deciding or decision-making?

A S Artz1, S Chow2.   

Abstract

Mesh：

Year:  2016        PMID： 27042839     DOI： 10.1038/bmt.2016.86

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Monetary losses do not loom large in later life: age differences in the framing effect.

Authors:  Joseph A Mikels; Andrew E Reed
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-06-04       Impact factor: 4.077

2.  Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.

Authors:  Esa Jantunen; Carmen Canals; Alessandro Rambaldi; Gert Ossenkoppele; Bernardino Allione; Didier Blaise; Eulogio Conde; Hervè Tilly; Gordon Cook; Fiona Clark; Andrea Gallamini; Andrew Haynes; Nicolas Mounier; Peter Dreger; Michael Pfreundschuh; Anna Sureda
Journal:  Haematologica       Date:  2008-10-06       Impact factor: 9.941

3.  Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

Authors:  Brian L McClune; Daniel J Weisdorf; Tanya L Pedersen; Gisela Tunes da Silva; Martin S Tallman; Jorge Sierra; John Dipersio; Armand Keating; Robert P Gale; Biju George; Vikas Gupta; Theresa Hahn; Luis Isola; Madan Jagasia; Hillard Lazarus; David Marks; Richard Maziarz; Edmund K Waller; Chris Bredeson; Sergio Giralt
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

4.  Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.

Authors:  Lori S Muffly; Melissa Boulukos; Kate Swanson; Masha Kocherginsky; Paula Del Cerro; Linda Schroeder; Lisa Pape; Martine Extermann; Koen Van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2012-11-15       Impact factor: 5.742

5.  Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Authors:  John T Horan; Brent R Logan; Manza-A Agovi-Johnson; Hillard M Lazarus; Andrea A Bacigalupo; Karen K Ballen; Christopher N Bredeson; Matthew H Carabasi; Vikas Gupta; Gregory A Hale; Hanna Jean Khoury; Mark B Juckett; Mark R Litzow; Rodrigo Martino; Philip L McCarthy; Franklin O Smith; J Douglas Rizzo; Marcelo C Pasquini
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

6.  Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.

Authors:  Mohamed L Sorror; Brenda M Sandmaier; Barry E Storer; Georg N Franke; Ginna G Laport; Thomas R Chauncey; Edward Agura; Richard T Maziarz; Amelia Langston; Parameswaran Hari; Michael A Pulsipher; Wolfgang Bethge; Firoozeh Sahebi; Benedetto Bruno; Michael B Maris; Andrew Yeager; Finn Bo Petersen; Lars Vindeløv; Peter A McSweeney; Kai Hübel; Marco Mielcarek; George E Georges; Dietger Niederwieser; Karl G Blume; David G Maloney; Rainer Storb
Journal:  JAMA       Date:  2011-11-02       Impact factor: 56.272

7.  Differences in Risk Aversion between Young and Older Adults.

Authors:  Steven M Albert; John Duffy
Journal:  Neurosci Neuroecon       Date:  2012-01-15

8.  Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Guido Marcucci; Deedra Nicolet; Kati S Maharry; Heiko Becker; Susan P Whitman; Klaus H Metzeler; Sebastian Schwind; Yue-Zhong Wu; Jessica Kohlschmidt; Mark J Pettenati; Nyla A Heerema; AnneMarie W Block; Shivanand R Patil; Maria R Baer; Jonathan E Kolitz; Joseph O Moore; Andrew J Carroll; Richard M Stone; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

9.  Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

Authors:  Steven M Devine; Kouros Owzar; William Blum; Flora Mulkey; Richard M Stone; Jack W Hsu; Richard E Champlin; Yi-Bin Chen; Ravi Vij; James Slack; Robert J Soiffer; Richard A Larson; Thomas C Shea; Vera Hars; Alexander B Sibley; Sergio Giralt; Shelly Carter; Mary M Horowitz; Charles Linker; Edwin P Alyea
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

10.  Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Authors:  Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Martin Höglund
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113
View more
  2 in total

Review 1.  Aging: Treating the Older Patient.

Authors:  Ashley Rosko; Andrew Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-15       Impact factor: 5.742

2.  Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

Authors:  Lori Muffly; Marcelo C Pasquini; Michael Martens; Ruta Brazauskas; Xiaochun Zhu; Kehinde Adekola; Mahmoud Aljurf; Karen K Ballen; Ashish Bajel; Frederic Baron; Minoo Battiwalla; Amer Beitinjaneh; Jean-Yves Cahn; Mathew Carabasi; Yi-Bin Chen; Saurabh Chhabra; Stefan Ciurea; Edward Copelan; Anita D'Souza; John Edwards; James Foran; Cesar O Freytes; Henry C Fung; Robert Peter Gale; Sergio Giralt; Shahrukh K Hashmi; Gerhard C Hildebrandt; Vincent Ho; Ann Jakubowski; Hillard Lazarus; Marlise R Luskin; Rodrigo Martino; Richard Maziarz; Philip McCarthy; Taiga Nishihori; Rebecca Olin; Richard F Olsson; Attaphol Pawarode; Edward Peres; Andrew R Rezvani; David Rizzieri; Bipin N Savani; Harry C Schouten; Mitchell Sabloff; Matthew Seftel; Sachiko Seo; Mohamed L Sorror; Jeff Szer; Baldeep M Wirk; William A Wood; Andrew Artz
Journal:  Blood       Date:  2017-07-03       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.